Thomas Pabst (T Pabst)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 92

Top Topics

Acute Myeloid Leukemia

Newly Diagnosed

Epstein Barr Virus

Stem Cell Transplantation

Top Venues

Hematological oncology

Bone marrow transplantation

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Katja Seipel, Harpreet Mandhair, Vera Ulrike Bacher, Thomas Pabst
FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology 46 (4) (2024)
Meral Beksac, Diderik-Jan Eikema, Linda Koster, Cyrille Hulin, Xavier Poire, Rose-Marie Hamladji, Tomasz Gromek, Ali Bazarbachi, Zubeyde Nur Ozkurt, Thomas Pabst, Tarek Ben Othman, Juergen Finke, Olga Pirogova, Depei Wu, Amjad Hayat, Inken Hilgendorf, Eleni Tholouli, Liesbeth C de Wreede, Stefan O Schönland, Laurent Garderet, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J Hayden, Ibrahim Yakoub-Agha, Donal P McLornan
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation (2024)
Michèle Hoffmann, Yara Banz, Jörg Halter, Jacqueline Schoumans, Joëlle Tchinda, Vera Ulrike Bacher, Thomas Pabst
True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report. Current oncology (Toronto, Ont.) 31 (4) (2024)
Meral Beksac, Diderik-Jan Eikema, Linda Koster, Cyrille Hulin, Xavier Poire, Rose-Marie Hamladji, Tomasz Gromek, Ali Bazarbachi, Zubeyde Nur Ozkurt, Thomas Pabst, Tarek Ben Othman, Juergen Finke, Olga Pirogova, Depei Wu, Amjad Hayat, Inken Hilgendorf, Eleni Tholouli, Liesbeth C de Wreede, Stefan O Schönland, Laurent Garderet, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J Hayden, Ibrahim Yakoub-Agha, Donal P McLornan
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Katja Seipel, Harpreet Mandhair, Vera Ulrike Bacher, Thomas Pabst
FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology 46 (4) (2024)
Michèle Hoffmann, Yara Banz, Jörg Halter, Jacqueline Schoumans, Joëlle Tchinda, Vera Ulrike Bacher, Thomas Pabst
True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report. Current oncology (Toronto, Ont.) 31 (4) (2024)
Selin G Ayçiçek, Dilara Akhoundova, Vera Ulrike Bacher, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Thomas Pabst
Determinants of Interpatient Variability in Treosulfan Pharmacokinetics in AML Patients Undergoing Autologous Stem Cell Transplantation. International journal of molecular sciences 25 (15) (2024)
Sikander Ailawadhi, Bertrand Arnulf, Krina K Patel, Michele Cavo, Ajay K Nooka, Salomon Manier, Natalie S Callander, Luciano José Megale Costa, Ravi Vij, Nizar J Bahlis, Philippe Moreau, Scott R Solomon, Ingerid Weum Abrahamsen, Rachid C Baz, Annemiek Broijl, Christine Chen, Sundar Jagannath, Noopur Raje, Christof Scheid, Michel Delforge, Reuben Benjamin, Thomas Pabst, Shinsuke Iida, Jesus G Berdeja, Sergio A Giralt, Anna Truppel-Hartmann, Yanping Chen, Xiaobo Zhong, Fan Wu, Julia Piasecki, Laurie Eliason, Devender S Dhanda, Jasper Felten, Andrea Caia, Mark Cook, Mihaela Popa-Mckiver, Paula Rodriguez Otero
Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses. Blood (2024)
Thomas Pabst, Vera Ulrike Bacher
Boosting CAR T cells against lymphomas. Blood 144 (7) (2024)
Michèle Hoffmann, Yara Banz, Jörg Halter, Jacqueline Schoumans, Joëlle Tchinda, Vera Ulrike Bacher, Thomas Pabst
True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report. Current oncology (Toronto, Ont.) 31 (4) (2024)
Katja Seipel, Nuria Z Veglio, Henning Nilius, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst
Rising Prevalence of Low-Frequency PPM1D Gene Mutations after Second HDCT in Multiple Myeloma. Current issues in molecular biology 46 (8) (2024)
Meral Beksac, Diderik-Jan Eikema, Linda Koster, Cyrille Hulin, Xavier Poire, Rose-Marie Hamladji, Tomasz Gromek, Ali Bazarbachi, Zubeyde Nur Ozkurt, Thomas Pabst, Tarek Ben Othman, Juergen Finke, Olga Pirogova, Depei Wu, Amjad Hayat, Inken Hilgendorf, Eleni Tholouli, Liesbeth C de Wreede, Stefan O Schönland, Laurent Garderet, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J Hayden, Ibrahim Yakoub-Agha, Donal P McLornan
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Katja Seipel, Nuria Z Veglio, Henning Nilius, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst
Rising Prevalence of Low-Frequency PPM1D Gene Mutations after Second HDCT in Multiple Myeloma. Current issues in molecular biology 46 (8) (2024)
Julian Mehl, Dilara Akhoundova, Vera Ulrike Bacher, Barbara Jeker, Gaëlle Rhyner Agocs, Axel Ruefer, Susanne Soltermann, Martin Soekler, Annette Winkler, Michael Daskalakis, Thomas Pabst
Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery. Cancers 16 (10) (2024)
Gertrud Wiedemann, Vera Ulrike Bacher, Raphael Joncourt, Françoise Solly, Corinne C Widmer, Sacha Zeerleder, Urban Novak, Thomas Pabst, Naomi A Porret
A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications. International journal of molecular sciences 25 (16) (2024)
Meral Beksac, Diderik-Jan Eikema, Linda Koster, Cyrille Hulin, Xavier Poire, Rose-Marie Hamladji, Tomasz Gromek, Ali Bazarbachi, Zubeyde Nur Ozkurt, Thomas Pabst, Tarek Ben Othman, Juergen Finke, Olga Pirogova, Depei Wu, Amjad Hayat, Inken Hilgendorf, Eleni Tholouli, Liesbeth C de Wreede, Stefan O Schönland, Laurent Garderet, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J Hayden, Ibrahim Yakoub-Agha, Donal P McLornan
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Danaë Martinez Flores, Dilara Akhoundova, Katja Seipel, Myriam Legros, Marie-Noelle Kronig, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines 12 (7) (2024)
Matthias Eggimann, Dilara Akhoundova, Henning Nilius, Michèle Hoffmann, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation. Cancers 16 (10) (2024)
Katja Seipel, Nuria Z Veglio, Henning Nilius, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst
Rising Prevalence of Low-Frequency PPM1D Gene Mutations after Second HDCT in Multiple Myeloma. Current issues in molecular biology 46 (8) (2024)
Julian Mehl, Dilara Akhoundova, Vera Ulrike Bacher, Barbara Jeker, Gaëlle Rhyner Agocs, Axel Ruefer, Susanne Soltermann, Martin Soekler, Annette Winkler, Michael Daskalakis, Thomas Pabst
Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery. Cancers 16 (10) (2024)
Danaë Martinez Flores, Dilara Akhoundova, Katja Seipel, Myriam Legros, Marie-Noelle Kronig, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines 12 (7) (2024)
Matthias Eggimann, Dilara Akhoundova, Henning Nilius, Michèle Hoffmann, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation. Cancers 16 (10) (2024)
Danaë Martinez Flores, Dilara Akhoundova, Katja Seipel, Myriam Legros, Marie-Noelle Kronig, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines 12 (7) (2024)
Selin G Ayçiçek, Dilara Akhoundova, Vera Ulrike Bacher, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Thomas Pabst
Determinants of Interpatient Variability in Treosulfan Pharmacokinetics in AML Patients Undergoing Autologous Stem Cell Transplantation. International journal of molecular sciences 25 (15) (2024)
Meral Beksac, Diderik-Jan Eikema, Linda Koster, Cyrille Hulin, Xavier Poire, Rose-Marie Hamladji, Tomasz Gromek, Ali Bazarbachi, Zubeyde Nur Ozkurt, Thomas Pabst, Tarek Ben Othman, Juergen Finke, Olga Pirogova, Depei Wu, Amjad Hayat, Inken Hilgendorf, Eleni Tholouli, Liesbeth C de Wreede, Stefan O Schönland, Laurent Garderet, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J Hayden, Ibrahim Yakoub-Agha, Donal P McLornan
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT. Bone marrow transplantation 59 (4) (2024)
Katja Seipel, Harpreet Mandhair, Vera Ulrike Bacher, Thomas Pabst
FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology 46 (4) (2024)
Gertrud Wiedemann, Vera Ulrike Bacher, Raphael Joncourt, Françoise Solly, Corinne C Widmer, Sacha Zeerleder, Urban Novak, Thomas Pabst, Naomi A Porret
A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications. International journal of molecular sciences 25 (16) (2024)
Rama Al Hamed, Myriam Labopin, De-Pei Wu, Tobias Gedde-Dahl, Mahmoud Aljurf, Edouard Forcade, Urpu Salmenniemi, Jakob R Passweg, Johan Maertens, Thomas Pabst, Jurjen Versluis, Maija Itäla-Remes, Xiao-Jun Huang, Gwendolyn Van Gorkom, Thomas Schroeder, Jaime Sanz Caballer, Didier Blaise, Péter Reményi, Urs Schanz, Aleksandra Holowiecka, Norbert-Claude Gorin, Fabio Ciceri, Florent Malard
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT. Bone marrow transplantation (2024)
Michèle Hoffmann, Yara Banz, Jörg Halter, Jacqueline Schoumans, Joëlle Tchinda, Vera Ulrike Bacher, Thomas Pabst
True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report. Current oncology (Toronto, Ont.) 31 (4) (2024)
Valerie Wittibschlager, Vera Ulrike Bacher, Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Claudia Haslebacher, Michèle Hoffmann, Michael Daskalakis, Dilara Akhoundova, Thomas Pabst
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences 24 (6) (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Valerie Wittibschlager, Vera Ulrike Bacher, Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Claudia Haslebacher, Michèle Hoffmann, Michael Daskalakis, Dilara Akhoundova, Thomas Pabst
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences 24 (6) (2023)
Alexander D Heini, Vera Ulrike Bacher, Thomas Pabst
Identification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL). British journal of haematology (2023)
Katja Seipel, Mariesol Abbühl, Vera Ulrike Bacher, Henning Nilius, Michael Daskalakis, Thomas Pabst
Clinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy. Cancers 15 (11) (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Thilo Zander, Thomas Pabst, Sämi Schär, Stefan Aebi, Ulrich Mey, Urban Novak, Erika Lerch, Gaëlle Rhyner Agocs, Jeroen Goede, Zuzanna Maniecka, Stefanie Hayoz, Axel Rüfer, Christoph Renner, Christoph Driessen
Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial. Leukemia 37 (3) (2023)
Valerie Wittibschlager, Vera Ulrike Bacher, Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Claudia Haslebacher, Michèle Hoffmann, Michael Daskalakis, Dilara Akhoundova, Thomas Pabst
CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences 24 (6) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Thilo Zander, Thomas Pabst, Sämi Schär, Stefan Aebi, Ulrich Mey, Urban Novak, Erika Lerch, Gaëlle Rhyner Agocs, Jeroen Goede, Zuzanna Maniecka, Stefanie Hayoz, Axel Rüfer, Christoph Renner, Christoph Driessen
Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial. Leukemia 37 (3) (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Thilo Zander, Thomas Pabst, Sämi Schär, Stefan Aebi, Ulrich Mey, Urban Novak, Erika Lerch, Gaëlle Rhyner Agocs, Jeroen Goede, Zuzanna Maniecka, Stefanie Hayoz, Axel Rüfer, Christoph Renner, Christoph Driessen
Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial. Leukemia 37 (3) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Alexander D Heini, Philipp Beck, Vera Ulrike Bacher, Katja Seipel, Thilo Zander, Michael Daskalakis, Thomas Pabst
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia. Journal of clinical medicine 12 (6) (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Vera Ulrike Bacher, Evgenii Shumilov, Thomas Pabst
Increasing insight in the value of repetitive COVID-19 vaccination in patients with haematological malignancies in the Omicron era. British journal of haematology (2023)
Jakob R Passweg, Helen Baldomero, Marc Ansari, Caroline Arber, Yves Chalandon, Michael Daskalakis, Miriam Diepold, Tamara Diesch-Furlanetto, Michel A Duchosal, Sabine Gerull, Tayfun Güngör, Dominik Heim, Felicitas Hitz, Andreas Holbro, Stavroula Masouridi-Levrat, Gayathri Nair, Urban Novak, Thomas Pabst, Christoph Renner, Georg Stussi, Dominik Schneidawind, Urs Schanz, Luciano Wannesson, Jörg P Halter, null null
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021. Hematological oncology (2023)
Alexander D Heini, Philipp Beck, Vera Ulrike Bacher, Katja Seipel, Thilo Zander, Michael Daskalakis, Thomas Pabst
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia. Journal of clinical medicine 12 (6) (2023)
Michael Fuchs, Anne Sophie Jacob, Helen Kaul, Carsten Kobe, Georg Kuhnert, Thomas Pabst, Richard Greil, Paul J Bröckelmann, Max S Topp, Marianne Just, Bernd Hertenstein, Martin Soekler, Martin Vogelhuber, Josée M Zijlstra, Ulrich Bernd Keller, Stefan W Krause, Ulrich Dührsen, Julia Meissner, Andreas Viardot, Hans-Theodor Eich, Christian Baues, Volker Diehl, Andreas Rosenwald, Ina Buehnen, Bastian von Tresckow, Markus Dietlein, Peter Borchmann, Andreas Engert, Dennis A Eichenauer
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma. Leukemia (2023)
Selina Bühler, Dilara Akhoundova, Barbara Jeker, Myriam Legros, Katja Seipel, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma. Cancers 15 (2) (2023)
Alexander D Heini, Philipp Beck, Vera Ulrike Bacher, Katja Seipel, Thilo Zander, Michael Daskalakis, Thomas Pabst
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia. Journal of clinical medicine 12 (6) (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Jacobien R Hilberink, Isabelle A van Zeventer, Dana A Chitu, Thomas Pabst, Saskia K Klein, Georg Stussi, Laimonas Griskevicius, Peter J M Valk, Jacqueline Cloos, Arjan A van de Loosdrecht, Dimitri Breems, Danielle van Lammeren-Venema, Rinske Boersma, Mojca Jongen-Lavrencic, Martin Fehr, Mels Hoogendoorn, Markus Gabriel Manz, Maaike Söhne, Rien van Marwijk Kooy, Dries Deeren, Marjolein W M van der Poel, Marie Cecile Legdeur, Lidwine Tick, Yves Chalandon, Emanuele Ammatuna, Sabine Blum, Bob Löwenberg, Gert J Ossenkoppele, null null, null null, Gerwin Huls
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine. Blood cancer journal 13 (1) (2023)
Jia Chen, Myriam Labopin, Thomas Pabst, Xi Zhang, Erlie Jiang, Alessandra Tucci, Jan Cornelissen, Ellen Meijer, Irma Khevelidze, Emmanuelle Polge, Depei Wu, Florent Malard, Norbert-Claude Gorin
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT. Bone marrow transplantation (2023)
Tim Lakomy, Dilara Akhoundova, Henning Nilius, Marie-Noëlle Kronig, Urban Novak, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules 13 (2) (2023)
Jesse Marc Tettero, Yara Buisman, Lok Lam Ngai, Costa Bachas, Bjorn Tore Gjertsen, Angèle Kelder, Arjan A van de Loosdrecht, Markus Gabriel Manz, Thomas Pabst, Willemijn Scholten, Gert J Ossenkoppele, Jacqueline Cloos, David C de Leeuw
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML. HemaSphere 7 (12) (2023)
Fabrizio Huwyler, Rebekka Kunz, Vera Ulrike Bacher, Michèle Hoffmann, Urban Novak, Michael Daskalakis, Yara Banz, Thomas Pabst
Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma. Cancers 15 (7) (2023)
Camille Perroud, Dario Thurian, Martin Andres, Arnaud Künzi, Gertrud Wiedemann, Sacha Zeerleder, Vera Ulrike Bacher, Thomas Pabst, Yara Banz, Naomi Porret, Ekaterina Rebmann
Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma. Hematological oncology (2023)
Thilo Zander, Thomas Pabst, Sämi Schär, Stefan Aebi, Ulrich Mey, Urban Novak, Erika Lerch, Gaëlle Rhyner Agocs, Jeroen Goede, Zuzanna Maniecka, Stefanie Hayoz, Axel Rüfer, Christoph Renner, Christoph Driessen
Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial. Leukemia (2023)
Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Vera Ulrike Bacher, Thomas Pabst
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology (Toronto, Ont.) 30 (12) (2023)
Thilo Zander, Thomas Pabst, Sämi Schär, Stefan Aebi, Ulrich Mey, Urban Novak, Erika Lerch, Gaëlle Rhyner Agocs, Jeroen Goede, Zuzanna Maniecka, Stefanie Hayoz, Axel Rüfer, Christoph Renner, Christoph Driessen
Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial. Leukemia 37 (3) (2023)
Jaime Sanz Caballer, Myriam Labopin, Thomas Pabst, Jurjen Versluis, Gwendolyn Van Gorkom, Ellen Meijer, Tobias Gedde-Dahl, Juan Montoro Gómez, William Arcese, José Antonio Pérez-Simón, Nicolaas Schaap, Johan Maertens, Radovan Vrhovac, Francesco Lanza, Norbert-Claude Gorin, Florent Malard, Fabio Ciceri
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation (2023)
Katja Seipel, Scarlett Kohler, Vera Ulrike Bacher, Thomas Pabst
HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. Current issues in molecular biology 45 (9) (2023)
Cédric Gillich, Dilara Akhoundova, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Katja Seipel, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma. Cancers 15 (10) (2023)
Selina Bühler, Dilara Akhoundova, Barbara Jeker, Myriam Legros, Katja Seipel, Michael Daskalakis, Vera Ulrike Bacher, Thomas Pabst
Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma. Cancers 15 (2) (2023)
Alexander D Heini, Ulrike Bacher, Marie-Noëlle Kronig, Gertrud Wiedemann, Urban Novak, Sacha Zeerleder, Behrouz Mansouri Taleghani, Michael Daskalakis, Thomas Pabst
Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center. Bone marrow transplantation 57 (6) (2022)
Christian Rausch, Vera Ulrike Bacher, Manuela Rabaglio, Corinne Vorburger, Anke Klingenberg, Yara Banz, Michael Daskalakis, Thomas Pabst
Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study. Journal of clinical medicine 11 (18) (2022)
Jeroen J W M Janssen, B Löwenberg, Markus Gabriel Manz, B J Biemond, Peter E Westerweel, Saskia K Klein, M Fehr, H A M Sinnige, A Efthymiou, M C J C Legdeur, Thomas Pabst, M Gregor, M W M van der Poel, D Deeren, Lidwine W Tick, M Jongen-Lavrencic, F van Obbergh, R S Boersma, O de Weerdt, Yves Chalandon, D Heim, Olivier Spertini, G van Sluis, C Graux, G Stüssi, Y van Norden, G J Ossenkoppele
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome. Leukemia 36 (9) (2022)
Jeanne Bohler, Vera Ulrike Bacher, Yara Banz, Raphael Stadelmann, Michael Medinger, Thilo Zander, Thomas Pabst
Blinatumomab in Relapsed/Refractory Burkitt Lymphoma. Cancers 15 (1) (2022)
Alexander D Heini, Vera Ulrike Bacher, Naomi A Porret, Gertrud Wiedemann, Myriam Legros, Denise Stalder Zeerleder, Katja Seipel, Urban Novak, Michael Daskalakis, Thomas Pabst
Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma. Cells 11 (17) (2022)
Ekaterina Gurevich, Michael Hayoz, Yolanda Aebi, Carlo R Largiadèr, Behrouz Mansouri Taleghani, Vera Ulrike Bacher, Thomas Pabst
Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML. Cancers 14 (4) (2022)
Jeanne Bohler, Vera Ulrike Bacher, Yara Banz, Raphael Stadelmann, Michael Medinger, Thilo Zander, Thomas Pabst
Blinatumomab in Relapsed/Refractory Burkitt Lymphoma. Cancers 15 (1) (2022)
Katja Seipel, Naomi A Porret, Gertrud Wiedemann, Barbara Jeker, Vera Ulrike Bacher, Thomas Pabst
sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma. Current issues in molecular biology 44 (4) (2022)
Katja Seipel, Yvo Brügger, Harpreet K Mandhair, Vera Ulrike Bacher, Thomas Pabst
Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia. International journal of molecular sciences 23 (20) (2022)
Jeanne Bohler, Vera Ulrike Bacher, Yara Banz, Raphael Stadelmann, Michael Medinger, Thilo Zander, Thomas Pabst
Blinatumomab in Relapsed/Refractory Burkitt Lymphoma. Cancers 15 (1) (2022)
Tanja Stoffel, Vera Ulrike Bacher, Yara Banz, Michael Daskalakis, Urban Novak, Thomas Pabst
BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL-A Pilot Study. Journal of clinical medicine 11 (13) (2022)
Sarah Farag, Ulrike Bacher, Barbara Jeker, Myriam Legros, Gaelle Rhyner, Jean-Marc Lüthi, Julian Schardt, Thilo Zander, Michael Daskalakis, Behrouz Mansouri, Chantal Manz, Thomas Pabst
Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial. Bone marrow transplantation 57 (6) (2022)
Simona Gössi, Vera Ulrike Bacher, Claudia Haslebacher, Michael Nagler, Franziska Suter, Cornelia Staehelin, Urban Novak, Thomas Pabst
Humoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell Therapy. Cancers 14 (14) (2022)
Jeanne Bohler, Vera Ulrike Bacher, Yara Banz, Raphael Stadelmann, Michael Medinger, Thilo Zander, Thomas Pabst
Blinatumomab in Relapsed/Refractory Burkitt Lymphoma. Cancers 15 (1) (2022)
Evgenii Shumilov, Paolo Mazzeo, Martin S Zinkernagel, Myriam Legros, Naomi Porret, Lorenz Romagna, Detlef Haase, Georg Lenz, Urban Novak, Yara Banz, Thomas Pabst, Vera Ulrike Bacher
Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology. Current oncology (Toronto, Ont.) 29 (2) (2022)
Vera Rentsch, Katja Seipel, Yara Banz, Gertrud Wiedemann, Naomi A Porret, Vera Ulrike Bacher, Thomas Pabst
Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy. Cancers 14 (10) (2022)
Melanie Maechler, Vera Ulrike Bacher, Michael Daskalakis, Henning Nilius, Michael Nagler, Behrouz Mansouri Taleghani, Barbara Jeker, Thomas Pabst
Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients. Hematological oncology (2022)
Anina Mathys, Vera Ulrike Bacher, Yara Banz, Myriam Legros, Behrouz Mansouri Taleghani, Urban Novak, Thomas Pabst
Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre-CAR T-cell era. Hematological oncology (2021)
Evgenii Shumilov, Inna Shakhanova, Johanna Flach, Nicole Schmidt, Susanne Buerki, Myriam Legros, Marie-Noëlle Kronig, Yishai Ofran, Sabine Gerull, Michael Medinger, Behrouz Mansouri Taleghani, Jakob Passweg, Joerg P Halter, Ulrike Bacher, Thomas Pabst
Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation. Bone marrow transplantation (2021)
Christophe Betticher, Vera Ulrike Bacher, Myriam Legros, Stefan Zimmerli, Yara Banz, Behrouz Mansouri Taleghani, Thomas Pabst
Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation. Hematological oncology 39 (1) (2020)
Johanna Flach, Evgenii Shumilov, Gertrud Wiedemann, Naomi Porret, Inna Shakhanova, Susanne Bürki, Myriam Legros, Raphael Joncourt, Thomas Pabst, Vera Ulrike Bacher
Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia. Hematological oncology 38 (4) (2020)
Florian Eicher, Behrouz Mansouri Taleghani, Christof Schild, Vera Ulrike Bacher, Thomas Pabst
Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels. Hematological oncology 38 (4) (2020)
Alexander D Heini, Rebecca Hugo, Martin D Berger, Urban Novak, Vera Ulrike Bacher, Thomas Pabst
Simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia. Hematological oncology 38 (1) (2019)
Evgenii Shumilov, Johanna Flach, Raphael Joncourt, Naomi Porret, Gertrud Wiedemann, Anne Angelillo-Scherrer, Lorenz Trümper, Martin Fiedler, Barbara Jeker, Ursula Amstutz, Thomas Pabst, Vera Ulrike Bacher
Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations. Hematological oncology 37 (3) (2019)
Sebastian Moser, Vera Ulrike Bacher, Barbara Jeker, Behrouz Mansouri Taleghani, Daniel Betticher, Axel Ruefer, Thomas Egger, Urban Novak, Thomas Pabst
Autologous stem cell transfusions on multiple days in patients with multiple myeloma-Does it matter? Hematological oncology 37 (5) (2019)
Ursina Gössi, Barbara Jeker, Behrouz Mansouri Taleghani, Ulrike Bacher, Urban Novak, Daniel Betticher, Thomas Egger, Thilo Zander, Thomas Pabst
Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograft. Hematological oncology 36 (2) (2018)
Alexandra Junge, Ulrike Bacher, Beatrice U Mueller, Peter Keller, Max Solenthaler, Thomas Pabst
Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression. Hematological oncology (2018)
Sarah Farag, Barbara Jeker, Ulrike Bacher, Behrouz Mansouri Taleghani, Beatrice U Mueller, Urban Novak, Thomas Pabst
Dose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patients. Hematological oncology 36 (4) (2018)